Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0KZ2D
|
|||
Former ID |
DNC006495
|
|||
Drug Name |
1-valproylamido-5-sulfonamidoindane
|
|||
Synonyms |
CHEMBL204941; 1-valproylamido-5-sulfonamidoindane; Indanesulfonamide Derivative 11a; BDBM11030
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H26N2O3S
|
|||
Canonical SMILES |
CCCC(CCC)C(=O)NC1CCC2=C1C=CC(=C2)S(=O)(=O)N
|
|||
InChI |
1S/C17H26N2O3S/c1-3-5-12(6-4-2)17(20)19-16-10-7-13-11-14(23(18,21)22)8-9-15(13)16/h8-9,11-12,16H,3-7,10H2,1-2H3,(H,19,20)(H2,18,21,22)
|
|||
InChIKey |
FCGKZIRRZCVIGR-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J Med Chem. 2006 May 4;49(9):2743-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.